Urgency Urinary Incontinence
11
3
5
6
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 11 trials
100.0%
+13.5% vs benchmark
36%
4 trials in Phase 3/4
33%
2 of 6 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 6 completed trials
Clinical Trials (11)
Effect of Behavioral Sleep Intervention on Lower Urinary Tract Symptoms in Older Women
Investigation of Brain Mechanisms Involved in the Urinary Continence Mechanism Associated With Aging
Investigation of Brain Mechanisms Involved in Urgency Urinary Incontinence
Reduced-dose Botox for Urgency Incontinence Among Elder Females
Behavioral Interventions Versus Pelvic Floor Muscle Therapy as Adjuncts to Anticholinergic Pharmacotherapy for Urgency Urinary Incontinence: A Non-Inferiority Trial
Beta-Agonist Versus OnabotulinumtoxinA Trial for Urgency Urinary Incontinence
Reduction in Number of Botox Injections for Urgency Urinary Incontinence
Repetitive Transcranial Magnetic Stimulation (rTMS) on Neurogenic Overactive Bladder in Stroke
Sacral Neuromodulation and the Microbiome
eCoin Tibial Nerve Stimulation for OAB
A Study to Estimate the Efficacy and Safety of Solifenacin in Female With Stress Urinary Incontinence and Urgency Urinary Incontinence